The current studies newly identified a molecular mechanism governing this phenomenon: BMAL1 directly interacts with HIF2A to form a transcriptionally active heterodimer, which drives the circadian variation of myocardial injury in both the acute and long-term phases in mice post-MI. The gene discussed is BMAL1; the disease is myocardial infarction.